Zahraa Al-Delfi

Miss Zahraa Al-Delfi

Higher Degree by Research Candidate

School of Medicine

College of Health


Language Competency
Arabic Can read, write, speak and understand spoken
English Can read, write, speak and understand spoken

Date Institution name Country Title
2026 University of Adelaide Australia PhD
2021 The University of Adelaide Australia Master of Biotechnology (Biomedical)
2018 The University of Adelaide Australia Bachelor of Science

Year Citation
2026 Santos, R., Mekonnen, Z. A., Yeow, A. E. L., Whelan, D. M., Al-Delfi, Z., Eyre, N. S., . . . Grubor-Bauk, B. (2026). Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus. npj Vaccines, 11(1), 35-1-35-14.
DOI
2025 Liu, D., Wang, X., Xu, L., Al-Delfi, Z. N. S., Mekonnen, Z. A., Gao, S., . . . Zhao, C. -X. (2025). Screening lipid nanoparticles using DNA barcoding and qPCR. Colloids and Surfaces B: Biointerfaces, 251, 114598-1-114598-11.
DOI Scopus6 WoS4 Europe PMC3
2025 Garcia-Valtanen, P., Yeow, A. E. L., Mekonnen, Z. A., Whelan, D. M., Santos, R., Al-Delfi, Z., . . . Grubor-Bauk, B. (2025). Thermostable unit solid dose formulations for subcutaneous administration of DNA vaccines. Molecular Therapy Nucleic Acids, 36(3), 10 pages.
DOI
2022 Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23.
DOI Scopus213 WoS206 Europe PMC211
2022 Perkins, G. B., Tunbridge, M., Salehi, T., Chai, C. S., Kireta, S., Johnston, J., . . . Coates, P. T. (2022). Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19. Kidney International, 101(5), 1077-1080.
DOI Scopus12 WoS11 Europe PMC12
2022 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 100651-1-100651-17.
DOI Scopus36 WoS35 Europe PMC35
2021 Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection.
DOI
2020 Mekonnen, Z. A., Masavuli, M. G., Yu, W., Gummow, J., Whelan, D. M., Al-Delfi, Z., . . . Grubor-Bauk, B. (2020). Enhanced T cell responses induced by a necrotic dendritic cell vaccine, expressing HCV NS3. Front Microbiol, 11(559105), 1-13.
DOI Scopus8 WoS6 Europe PMC7

Year Citation
2021 Ryan, F., Hope, C., Masavuli, M., Lynn, M., Mekonnen, Z., Lip Yeow, A. E., . . . Lynn, D. (2021). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
DOI Europe PMC1

Connect With Me

External Profiles

Other Links